| IMZISHEN JOHNSON & JOHNSON
1960323 01 May 2019 | on 17 Jan 2020 | Class 005 Class 005 Pharmaceutical Products Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, anti-allergic medications, and vaccines; human pharmaceutical preparations for the relief of pain | | | IMZIELDIO BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1818876 19 Jan 2017 | on 14 Nov 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents. | | | IMZEPAR UCB BIOPHARMA SPRL
1724571 20 Apr 2015 | on 09 Aug 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of central nervous system diseases and for the treatment of diseases of the immune system | | | IMZONTIX ASTRAZENECA AB
1607860 21 Dec 2012 | on 09 Jul 2013 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the metabolism, respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastrointestinal system; pharmaceutical preparations and substances for pain control, arthritis, infection, inflammation and diabetes; pharmaceutical preparations and substances for use in the field of anaesthesia, oncology, urology and gynaecology | | | IMZIG ARES TRADING S.A.
1516538 23 Feb 2011 | on 09 Aug 2017 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, namely preparations for the treatment of auto-immune diseases and disorders, immunological dysfunctions, allergies, tumors of the immunological organ; inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases, systemic inflammatory disorders; endocrinological diseases and disorders, namely growth disorders; metabolic diseases and disorders namely osteoarthritis, muscular dystrophy anemia; rheumatological diseases and disorders namely osteoarthritis, rheumatoid arthritis; musculoskeletal system, namely connective tissue diseases, cartilage diseases, arthropathic conditions, bone diseases, joint diseases, spinal diseases, cartilage injuries. | | | IMZORIX GLAXOSMITHKLINE BIOLOGICALS S.A.
1485236 15 Jun 2010 | on 06 Jan 2016 | Class 005 Class 005 Pharmaceutical Products Vaccines for human use. | | | IMZ & DESIGN URAL-TM CORPORATION
1143257 11 Jun 2002 | on 05 Nov 2003 | Class 012 Class 012 Vehicles and Products for locomotion by land, air or water Motorcycles, sidecars, structural parts and fittings thereof. | |